Abstract
A growing body of evidence indicates that microRNA23b (miR23b) is pleiotropic—it plays important roles in regulating physiological functions of cells, in regulating differentiation of cells and in regulating cellular immune responses. Our review of the literature showed that dysregulation of miR23b expression is implicated in the disruption of these cellular mechanisms and development of diseases such as cancer. MiR23b dysregulation appears to do this by modulating the expression level of candidate gene products involved in a network of signaling pathways including TGF-beta and Notch pathways that govern malignant properties of cancer cells such as motility and invasiveness. More recently, miR23b regulation of gene expression has also been associated with cancer stem cells and chemoresistance. Our review covers miR23b’s role in immunity, endothelial function, differentiation, and cancer as well as its potential for translation into future cancer diagnostics and therapeutics.
Similar content being viewed by others
References
Chalfie M, Horvitz HR, Sulston JE (1981) Mutations that lead to reiterations in the cell lineages of C. elegans. Cell 24(1):59–69
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843–854
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404(6775):293–296
Johnson SM, Lin SY, Slack FJ (2003) The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Dev Biol 259(2):364–379
Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110(5):563–574
Olsen PH, Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216(2):671–680
Yekta S, Shih IH, Bartel DP (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304(5670):594–596
Yi R, Qin Y, Macara IG, Cullen BR (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24):3011–3016
Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S et al (2003) The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112(3):317–327
Kimura H, Kawasaki H, Taira K (2004) Mouse microRNA-23b regulates expression of Hes1 gene in P19 cells. Nucleic Acids Symp Ser (Oxf) 48:213–214
Li X, Li XQ, Zhang JH, Chen WX, Liu J, Guo TN, et al. (2008) [Differential expression profiles of MicroRNA during the development of human cord blood CD34(+)CD38(−) cells to CD34(+)CD38(+) cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi;16(3):589–92
Hildebrand J, Rutze M, Walz N, Gallinat S, Wenck H, Deppert W et al (2011) A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol 131(1):20–29
Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R et al (2009) MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50(2):575–584
Yuan B, Dong R, Shi D, Zhou Y, Zhao Y, Miao M et al (2011) Down-regulation of miR-23b may contribute to activation of the TGF-beta1/Smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett 585(6):927–934
Leone V, D’Angelo D, Pallante P, Croce CM, Fusco A (2012) Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3. J Clin Endocrinol Metab 97(9):3292–3301
Dmitriev P, Barat A, Polesskaya A, O’Connell MJ, Robert T, Dessen P et al (2013) Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes. BMC Genomics 14:265
Ham O, Song BW, Lee SY, Choi E, Cha MJ, Lee CY et al (2012) The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials 33(18):4500–4507
Lin K, Hsu PP, Chen BP, Yuan S, Usami S, Shyy JY et al (2000) Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A 97(17):9385–9389
Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K et al (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108(9):3068–3071
Wang KC, Garmire LX, Young A, Nguyen P, Trinh A, Subramaniam S et al (2010) Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Proc Natl Acad Sci U S A 107(7):3234–3239
He J, Li Y, Yang X, He X, Zhang H, Zhang L (2012) The feedback regulation of PI3K-miR-19a, and MAPK-miR-23b/27b in endothelial cells under shear stress. Molecules 18(1):1–13
Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM et al (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14(3):249–256
Di Stefano V, Zaccagnini G, Capogrossi MC, Martelli F (2011) microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol 55(4):111–118
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31(6):659–666
Wei C, Henderson H, Spradley C, Li L, Kim IK, Kumar S et al (2013) Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One 8(5):e64396
O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10(2):111–122
Zheng J, Jiang HY, Li J, Tang HC, Zhang XM, Wang XR et al (2012) MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-kappaB signalling pathways. Allergy 67(3):362–370
Chen XM, O’Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS et al (2005) Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 175(11):7447–7456
Zhou R, Hu G, Gong AY, Chen XM (2010) Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 38(10):3222–3232
Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM (2009) NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog 5(12):e1000681
Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y et al (2012) The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 18(7):1077–1086
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999–3004
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866
Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P et al (2007) A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosom Cancer 46(4):336–347
Kowalewska M, Bakula-Zalewska E, Chechlinska M, Goryca K, Nasierowska-Guttmejer A, Danska-Bidzinska A et al (2013) microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report. Tumour Biol 34(4):2153–2160
Castilla MA, Moreno-Bueno G, Romero-Perez L, Van De Vijver K, Biscuola M, Lopez-Garcia MA et al (2011) Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223(1):72–80
Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S et al (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16(3):206–216
Sikand K, Slane SD, Shukla GC (2009) Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int 9:21
Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P (2009) The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 69(8):3356–3363
Sun T, Yang M, Chen S, Balk S, Pomerantz M, Hsieh CL et al (2012) The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Prostate 72(10):1093–1103
Ishteiwy RA, Ward TM, Dykxhoorn DM, Burnstein KL (2012) The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. PLoS One 7(12):e52106
He HC, Zhu JG, Chen XB, Chen SM, Han ZD, Dai QS et al (2012) MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Lett 586(16):2451–2458
Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239):762–765
Tian L, Fang YX, Xue JL, Chen JZ (2013) Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro. PLoS One 8(9):e75885
Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS et al (2012) miR-23b represses proto-oncogene SRC kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 72(24):6435–6446
Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK (2013) Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer. Cancer Res 73(9):2884–2896
Wu Q, Wang C, Lu Z, Guo L, Ge Q (2012) Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 413(13–14):1058–1065
Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G et al (2012) Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 31(38):4196–4206
Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L et al (2013) miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res 41(10):5400–5412
Chen L, Han L, Zhang K, Shi Z, Zhang J, Zhang A et al (2012) VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1alpha/VEGF and beta-catenin/Tcf-4 signaling. Neuro Oncol 14(8):1026–1036
Loftus JC, Ross JT, Paquette KM, Paulino VM, Nasser S, Yang Z et al (2012) miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. PLoS One 7(6):e39818
Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S et al (2011) Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2:554
Slaby O, Sachlova M, Brezkova V, Hezova R, Kovarikova A, Bischofova S et al (2013) Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer. Nutr Cancer 65(2):247–254
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M et al (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9(7):824–833
Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA et al (2013) MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila) 6(3):196–205
Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao YP et al (2013) Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev 14(1):139–143
Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S et al (2012) Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One 7(11):e50203
Liu Y, Borchert GL, Donald SP, Diwan BA, Anver M, Phang JM (2009) Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res 69(16):6414–6422
Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S et al (2010) miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29(35):4914–4924
Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW et al (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A 109(23):8983–8988
Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K et al (2013) MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One 8(7):e67686
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19
Bai L, Wei L, Wang J, Li X, He P (2006) Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Int J Gynecol Cancer 16(2):718–729
Au Yeung CL, Tsang TY, Yau PL, Kwok TT (2011) Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 30(21):2401–2410
Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 34(2):122–136
Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P et al (2009) MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276(11):2966–2982
Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A et al (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70(10):4163–4173
Li B, Sun M, Gao F, Liu W, Yang Y, Liu H et al (2013) Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma. Cell Physiol Biochem 32(6):1729–1740
Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L et al (2013) MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology 145(5):1133–43 e12
DeSano JT, Xu L (2009) MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J 11(4):682–692
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D et al (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3):592–603
Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M et al (2011) Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol 18(4):1166–1174
Geng J, Luo H, Pu Y, Zhou Z, Wu X, Xu W et al (2012) Methylation mediated silencing of miR-23b expression and its role in glioma stem cells. Neurosci Lett 528(2):185–189
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983–3988
Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X et al (2009) ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 22(6):817–823
Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H et al (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69(8):3382–3389
Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ et al (2008) Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6(7):1146–1153
van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70(12):5163–5173
Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K et al (2012) Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62(2):112–119
Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH, Kwon YD et al (2013) MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res 6(1):18
Liu Q, Li RT, Qian HQ, Wei J, Xie L, Shen J et al (2013) Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. Biomaterials 34(29):7191–7203
Acknowledgments
We would like to acknowledge support from the Delaware Bioscience Center for Advanced Technology (CAT) grant and the Cancer B Ware Foundation support. We would also like to extend our gratitude to the Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute. We thank Dr. Nicholas J. Petrelli sincerely for his help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Viswanathan, V., Fields, J. & Boman, B.M. The miRNA23b-regulated signaling network as a key to cancer development—implications for translational research and therapeutics. J Mol Med 92, 1129–1138 (2014). https://doi.org/10.1007/s00109-014-1208-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-014-1208-4